Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00478309 · ClinicalTrials.gov registry record · NA

Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants

A NA study of Colorectal Cancer and Healthy, no Evidence of Disease, sponsored by Fox Chase Cancer Center.

Completed
Registry status
NA
Development phase
697
Enrollment target
1
Study location

NCT00478309 is a NA study of Colorectal Cancer and Healthy, no Evidence of Disease that has completed, run by Fox Chase Cancer Center. The registered enrollment target is 697 participants, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00478309, a NA study of Colorectal Cancer and Healthy, no Evidence of Disease, has completed, sponsored by Fox Chase Cancer Center.

COMPLETED
Registry status
NA
Development phase
697 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: The Genetic Epidemiology and Risk Assessment program may be more effective than usual care in increasing the number of healthy participants who regularly receive screening for colorectal cancer. PURPOSE: This randomized clinical trial is studying the Genetic Epidemiology and Risk Assessment program to see how well it works compared with usual care to increase colorectal cancer screening in healthy participants.

Interventions

  • OTHER educational intervention
  • OTHER counseling intervention

Study Locations (1)

Pennsylvania

  • Fox Chase Cancer Center - Philadelphia - Philadelphia

Trial Details

FieldValue
Enrollment Target 697 participants
Start Date 2007-03
Phase NA

Sponsor

Fox Chase Cancer Center

183 total trials

What the Registry Record Tells You About NCT00478309

The ClinicalTrials.gov registry entry for NCT00478309 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 697 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,509-participant average among 369 other Colorectal Cancer trials with a reported enrollment target (54% lower). The listed sponsor is Fox Chase Cancer Center, which has 183 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which educational intervention is the first listed.

NCT00478309 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT00478309 about?

NCT00478309 is a clinical study titled "Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants". RATIONALE: The Genetic Epidemiology and Risk Assessment program may be more effective than usual care in increasing the number of healthy participants who regularly receive screening for colorectal cancer. PURPOSE: This randomized clinical trial is studying the Genetic Epidemiology and Risk Assessm...

What is the current status of trial NCT00478309?

This trial is currently completed. It is a NA study. The enrollment target is 697 participants. The study started on 2007-03.

What conditions does trial NCT00478309 study?

This clinical trial studies the following conditions: Colorectal Cancer, Healthy, no Evidence of Disease.

What interventions are being tested in trial NCT00478309?

The interventions under investigation include: educational intervention (OTHER), counseling intervention (OTHER).

Who is sponsoring clinical trial NCT00478309?

This trial is sponsored by Fox Chase Cancer Center, which has 183 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00478309 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Colorectal Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.